Gavin Ha
0000-0001-7578-7272
Publication & Citation Trends
Publications
0 total
Abstract PR005: Epigenetically Informed Therapeutic Strategies for DNA-Hypomethylated Prostate Cancer
Cited by 0
Semantic Scholar
Abstract 5322: Non-invasive tracking of clonal evolution and treatment response through liquid biopsies.
Cited by 0
Semantic Scholar
Abstract LB006: Prostate cancer phenotypes determined from circulating tumor DNA associate with outcomes to 177Lu-PSMA-617 therapy
Cited by 0
Semantic Scholar
Abstract LB433: Multi-omic reconstruction of metastatic prostate cancer evolution from rapid autopsy reveals polyclonal seeding and implications for liquid biopsy
Cited by 0
Semantic Scholar
Deep learning-based non-invasive profiling of tumor transcriptomes from cell-free DNA for precision oncology
Cited by 0
Semantic Scholar
Preeclampsia risk prediction from prenatal cell-free DNA screening OA
Cited by 19
Semantic Scholar
Abstract 1241: Deciphering heterogeneity and tumor evolution in bladder cancer using multi-omics and liquid biopsies from rapid autopsies
Cited by 0
Semantic Scholar
Abstract LB338: Genome-wide haplotype-specific copy number analysis from clinical targeted tumor sequencing data
Cited by 0
Semantic Scholar
Research Topics
Cancer Genomics and Diagnostics
(224)
Prostate Cancer Treatment and Research
(77)
Genetic factors in colorectal cancer
(50)
RNA modifications and cancer
(24)
Epigenetics and DNA Methylation
(23)
Affiliations
AstraZeneca (United Kingdom)
Broad Institute
James S. McDonnell Foundation
University of Hawaiʻi at Mānoa
BC Cancer Agency